ALS neuron damage reversed with new compound
New compound targets neurons that initiate voluntary movement After 60 days of treatment, diseased brain cells look like healthy cells More research needed before clinical trial can be initiated CHICAGO and EVANSTON— Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a…
Details